Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke

Table 3 Biomarkers and the risk of the primary outcome after AIS

	Model 1		Model 2
	OR (95% CI)	p value	OR (95% CI)	p value
Biomarkers (as continuous variables)
sIL-2Rα, per 100 pg/ml increase	1.235 (1.142–1.335)	0.000	1.197 (1.085–1.322)	0.000
IL-2, per 1 pg/ml increase	0.976 (0.957–0.995)	0.013	0.991 (0.965–1.017)	0.400
Biomarkers (as categorical variables)
sIL-2Rα, ≥ 971.44 pg/ml	5.957 (3.117–11.384)	0.000	5.577 (2.264–13.740)	0.000

Model 1 was an unadjusted logistic regression model. The variables in model 2 included age, admission NIHSS score, a history of diabetes mellitus, coronary heart disease, atrial fibrillation, recanalization treatment, neutrophil-to-lymphocyte ratio, glucose, total cholesterol, low-density lipoprotein, sIL-2Rα and IL-2 levels on admission

ISSN: 1742-2094